Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker EBS
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jul 1, 2026 | Paul Anthony Williams SVP, Products Business | EBS Emergent BioSolutions Inc. | Sale | 3,000 | $8.40 | $25.2K Sale | Form 4 ↗ |
| May 1, 2026 | Kathryn C. Zoon Director | EBS Emergent BioSolutions Inc. | Sale | 1,057 | $8.97 | $9,481 Sale | Form 4 ↗ |
| May 1, 2026 | Kathryn C. Zoon Director | EBS Emergent BioSolutions Inc. | Sale | 16,145 | $8.36 | $135.0K Sale | Form 4 ↗ |
| May 1, 2026 | Donald W. DeGolyer Director | EBS Emergent BioSolutions Inc. | Sale | 954 | $8.96 | $8,548 Sale | Form 4 ↗ |
| May 1, 2026 | Donald W. DeGolyer Director | EBS Emergent BioSolutions Inc. | Sale | 14,527 | $8.36 | $121.4K Sale | Form 4 ↗ |
| May 1, 2026 | Sujata Tyagi Dayal Director | EBS Emergent BioSolutions Inc. | Sale | 980 | $8.94 | $8,761 Sale | Form 4 ↗ |
| May 1, 2026 | Sujata Tyagi Dayal Director | EBS Emergent BioSolutions Inc. | Sale | 12,781 | $8.36 | $106.8K Sale | Form 4 ↗ |
| Apr 30, 2026 | Keith Katkin Director | EBS Emergent BioSolutions Inc. | Sale | 15,481 | $8.28 | $128.2K Sale | Form 4 ↗ |
| Apr 1, 2026 | Paul Anthony Williams SVP, Products Business | EBS Emergent BioSolutions Inc. | Sale | 4,000 | $8.44 | $33.8K Sale | Form 4 ↗ |
| Dec 5, 2025 | Ronald Richard Director | EBS Emergent BioSolutions Inc. | Sale | 14,884 | $11.90 | $177.1K Sale | Form 4 ↗ |
| Dec 5, 2025 | Ronald Richard Director | EBS Emergent BioSolutions Inc. | Sale | 7,100 | $12.11 | $86.0K Sale | Form 4 ↗ |
| Nov 10, 2025 | Donald W. DeGolyer Director | EBS Emergent BioSolutions Inc. | Sale | 17,801 | $10.54 | $187.6K Sale | Form 4 ↗ |
| Nov 7, 2025 | Sujata Tyagi Dayal Director | EBS Emergent BioSolutions Inc. | Sale | 8,552 | $10.00 | $85.5K Sale | Form 4 ↗ |
| Oct 7, 2025 | Coleen Glessner EVP, Quality & Ethics, and CPL | EBS Emergent BioSolutions Inc. | Sale | 30,608 | $10.00 | $306.1K Sale | Form 4 ↗ |
| Aug 15, 2025 | Kathryn C. Zoon Director | EBS Emergent BioSolutions Inc. | Sale | 7,086 | $8.87 | $62.9K Sale | Form 4 ↗ |
| Aug 12, 2025 | Donald W. DeGolyer Director | EBS Emergent BioSolutions Inc. | Sale | 7,844 | $8.65 | $67.9K Sale | Form 4 ↗ |
| May 23, 2025 | Keith Katkin Director | EBS Emergent BioSolutions Inc. | Sale | 7,844 | $6.30 | $49.4K Sale | Form 4 ↗ |
| May 13, 2025 | Joseph C. Papa President and CEO, Director | EBS Emergent BioSolutions Inc. | Buy | 60,000 | $5.83 | $349.8K Buy | Form 4 ↗ |
| Mar 12, 2025 | Neal Franklin Fowler Director | EBS Emergent BioSolutions Inc. | Sale | 35,000 | $5.83 | $204.1K Sale | Form 4 ↗ |
| Mar 12, 2025 | Kathryn C. Zoon Director | EBS Emergent BioSolutions Inc. | Sale | 10,000 | $5.73 | $57.3K Sale | Form 4 ↗ |
| Nov 12, 2024 | Donald W. DeGolyer Director | EBS Emergent BioSolutions Inc. | Sale | 25,000 | $10.91 | $272.8K Sale | Form 4 ↗ |
| Nov 11, 2024 | Marvin L. White Director | EBS Emergent BioSolutions Inc. | Sale | 14,287 | $11.97 | $171.0K Sale | Form 4 ↗ |
22 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 6:16 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances